AbbVie has scrapped an asset from its ongoing collaboration with Dragonfly Therapeutics, a spokesperson for the Chicago pharma confirmed to Fierce Biotech. “We have terminated clinical activity around ...
Nkarta, Inc. ((NKTX)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...
Pancreatic cancer (PC) is one of the deadliest cancers, often diagnosed at advanced, hard-to-treat stages. Current cell-based therapies like CAR-T cells face major hurdles, including tumor variability ...
One of the newest weapons that scientists have developed against cancer is a type of engineered immune cell known as CAR-NK (natural killer) cells. Similar to CAR-T cells, these cells can be ...
Sweet-sensing taste cells, supported by the protein c-Kit, show remarkable resilience when nerves are damaged, unlike other taste cells that quickly degenerate. Blocking c-Kit with the drug imatinib ...
Cayman Chemical, a global provider of life science research tools, and Akadeum Life Sciences, a leader in buoyancy-based cell separation technology, announced today a distribution partnership to ...
Dr Katy Rezvani reveals groundbreaking insights on enhancing CAR-NK cell therapy's effectiveness against solid tumors through innovative genetic strategies. In an interview with Targeted Oncology, ...
All five patients in a trial with recurrent glioblastoma given a combination of ImmunityBio's (NASDAQ:IBRX) natural killer (NK) cell therapy Anktiva and Novocure's (NASDAQ:NVCR) Optune Gio Tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results